ArticleActa endocrinologica (Bucharest, Romania : 2005)
INDEPENDENT AND COMBINED EFFECTS OF HYPERGLYCEMIA AND CHRONIC KIDNEY DISEASE ON BONE MINERAL DENSITY AND MICROARCHITECTURE.
Article in Acta endocrinologica (Bucharest, Romania : 2005). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Abnormal glucose metabolism (prediabetes and type 2 diabetes mellitus [T2DM]) and chronic kidney disease (CKD) are two conditions that frequently coexist and affect bone mass and microarchitecture. We investigated both independent and combined effects of abnormal glucose metabolism and chronic kidney disease (CKD) on bone mineral density (BMD) and microarchitecture. Methods: This observational, single center, prospective study recruited 604 men and postmenopausal women with prediabetes or T2DM and normal kidney function (n=365) or CKD (n=113) or with normal glucose tolerance (NGT) and normal kidney function (n=105) or CKD (n=21). We measured lumbar spine, femoral neck, 33% radius BMD and trabecular bone score (TBS). 25- hydroxyhydroxy-vitamin-D was sufficient in most patients (64.9%). Patients with T2DM were controlled on therapy (glycated hemoglobin 6.3% [5.8-6.6]). Results: Absolute BMD and T-score were significantly higher in prediabetes and T2DM than in NGT patients at all three sites. Irrespective of glycemic status, patients with CKD had similar BMD with patients with normal kidney function at all sites, even if they were 4-7 years older. TBS was similar in all groups. There was no association between HbA1c and BMD at any site or TBS. Conclusions: In conclusion, our study showed that impaired glucose metabolism (prediabetes or T2DM) and CKD have independent but no additive effects on bone mineral density and microarchitecture in patients with well-controlled diabetes and vitamin D sufficiency. This suggests that independent intensive treatment and screening could prevent bone loss and architectural damage in these 2 conditions that frequently coexist.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.